Medford, MA, United States of America

Andrew Yongky

This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Bristol-Myers Squibb Compnay. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Andrew Yongky. Retrieved from https://idiyas.com/inventor/andrew-yongky

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Andrew Yongky: Innovator at Bristol-Myers Squibb

Introduction

Andrew Yongky is an accomplished inventor based in Princeton, NJ. He is currently associated with Bristol-Myers Squibb Company, a leading global biopharmaceutical company. Although he holds no patents at this time, his contributions to the field of innovation are noteworthy.

Latest Patents

As of now, Andrew Yongky has not registered any patents. However, his work at Bristol-Myers Squibb may lead to future innovations that could significantly impact the industry.

Career Highlights

Andrew has built a career at Bristol-Myers Squibb, where he has been involved in various projects aimed at advancing healthcare solutions. His role in the company showcases his commitment to improving patient outcomes through innovative approaches.

Collaborations

Due to space constraints, the collaborations section will be omitted.

Conclusion

Andrew Yongky is a dedicated inventor whose work at Bristol-Myers Squibb reflects his passion for innovation in the biopharmaceutical sector. His future endeavors may lead to significant advancements in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…